US2013064846A1PendingUtilityA1

Neisserial antigens

Assignee: SCARLATO VINCENZOPriority: Nov 6, 1997Filed: Aug 23, 2012Published: Mar 14, 2013
Est. expiryNov 6, 2017(expired)· nominal 20-yr term from priority
A61P 37/04C07K 14/22A61K 38/00A61P 43/00A61P 31/04A61K 39/00
55
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides proteins from Neisseria meningitidis (strains A & B) and from Neisseria gonorrhoeae , including amino acid sequences, the corresponding nucleotide sequences, expression data, and serological data. The proteins are useful antigens for vaccines, immunogenic compositions, and/or diagnostics.

Claims

exact text as granted — not AI-modified
1 : An isolated protein comprising:
 (a) the amino acid sequence of SEQ ID NO: 654; or   (b) an amino acid sequence having 80% or greater sequence identity to the amino acid sequence of SEQ ID NO: 654; or   (b) a fragment of SEQ ID NO: 654 of at least 10 contiguous amino acids in length.   
     
     
         2 : The isolated protein of  claim 1  comprising (b). 
     
     
         3 : The isolated protein of  claim 2 , wherein the amino acid sequence has 90% or greater sequence identity to the amino acid sequence of SEQ ID NO: 654. 
     
     
         4 : The isolated protein of  claim 2 , wherein the amino acid sequence has 95% or greater sequence identity to the amino acid sequence of SEQ ID NO: 654. 
     
     
         5 : The isolated protein of  claim 1  comprising (c). 
     
     
         6 : A composition comprising the protein of any one of  claims 1 - 5  and an adjuvant. 
     
     
         7 : The composition of  claim 6  further comprising a pharmaceutically acceptable carrier.

Join the waitlist — get patent alerts

Track US2013064846A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.